Laboratorio Reig Jofre, S.A. (LON:0RB1)

London flag London · Delayed Price · Currency is GBP · Price in EUR
3.010
-0.020 (-0.66%)
At close: Jul 4, 2025
9.85%
Market Cap 210.39M
Revenue (ttm) 284.78M
Net Income (ttm) 9.09M
Shares Out n/a
EPS (ttm) n/a
PE Ratio 23.15
Forward PE 16.72
Dividend 0.03 (1.11%)
Ex-Dividend Date May 15, 2025
Volume 52
Average Volume 171
Open 3.010
Previous Close 3.030
Day's Range 3.010 - 3.010
52-Week Range 2.500 - 3.380
Beta 0.92
RSI 47.03
Earnings Date Jul 25, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1929
Employees 1,331
Stock Exchange London Stock Exchange
Ticker Symbol 0RB1
Full Company Profile

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 338.90 million, an increase of 6.59% compared to the previous year's 317.95 million. Earnings were 10.47 million, an increase of 11.27%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.